QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (220)	1/10/1998 8:43:00 PM
From: Joe Stephenson	Read Replies (1) of 1321

John...I can't help with regards to your first 4 questions, but I would also be interested if someone has or knows about this information. However, with reference to #5, QLTIF is going back to the FDA's ODAC hearing in March (18th or 19th I think) to re-present their data on photofrin for late stage cancer. Further clinical trials were not requested by the FDA in September '97. I think if the company re-presents in March then all of their ducks should be in order. I don't think they would want to go back again and not get a positive response. From what I have read, the early stage approval is considered more important anyway (larger market I think) than late stage stage (palliative) treatments. Hopefully this helps...and let's look forward to news from the AMD trials late this year. Regards, Joe Stephenson

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next